Advertisement

Leptomeningeal Cancer in the Pediatric Patient

  • Kathleen A. Neville
  • Susan M. Blaney
Part of the Cancer Treatment and Research book series (CTAR, volume 125)

Abstract

The treatment and prophylaxis of leptomeningeal leukemia and lymphoma in children has dramatically improved disease control and long-term survival. However, the treatment of other leptomeningeal cancers has been less successful and the neurologic morbidity associated with central nervous system-directed therapy has a significant long-term impact on quality of life. Further research is critical to identify new therapeutic strategies for children with or at high risk for leptomeningeal cancer.

Key words

Acute lymphoblastic leukemia neuroblastoma craniospinal irradiation prophylactic intrathecal therapy medulloblastoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Evans A, Gilbert E, Zandstra R. The increasing incidence of central nervous system leukemia in children. Cancer 1970; 26:404–407.PubMedGoogle Scholar
  2. 2.
    Hardisty R, Norman P. Meningeal leukemia. Arch Dis Child 1967; 42:441–447.PubMedGoogle Scholar
  3. 3.
    Bleyer W, Byrne T. Leptomeningeal cancer in leukemia and solid tumors. Curr Probl Cancer 1988; 4:185–238.CrossRefGoogle Scholar
  4. 4.
    Wasserstrom W, Glass J, Posner J. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982; 49:759–772.PubMedGoogle Scholar
  5. 5.
    Chamberlain M, Kormanik P. Prognostic significance of 111 indium-DTPA CSF flow studies in leptomeningeal metastases. Neurology 1996; 46:1674–1677.PubMedGoogle Scholar
  6. 6.
    Chamberlain M, Corey-Bloom J. Leptomeningeal metastases: 111 indium-DTPA CSF flow studies. Neurology 1991; 41:1765–1769.PubMedGoogle Scholar
  7. 7.
    Little J, Dale A, Okazaki H. Meningeal carcinomatosis. Arch Neurol 1974;30:138–143.PubMedGoogle Scholar
  8. 8.
    Olson M, Chernik N, Posner J. Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol 1974;30:122–137.PubMedGoogle Scholar
  9. 9.
    Theodore W, Gendelman S. Meningeal carcinomatosis. Arch Neurol 1981;38:696–699.PubMedGoogle Scholar
  10. 10.
    Kaplan J, DeSouza T, Farkash A, et al. Leptomeningeal metastases: comparison of clinical 0features and laboratory data of solid tumors, lymphomas, and leukemias. J Neurooncol. 1990;9:225–229.PubMedCrossRefGoogle Scholar
  11. 11.
    Freilich R, Krol G, DeAngelis L. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995;38:51–57.PubMedCrossRefGoogle Scholar
  12. 12.
    Mahmoud H, Rivera G, Hancock M, et al. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. New Engl J Med 1993; 329:314–319.PubMedCrossRefGoogle Scholar
  13. 13.
    Lauer S, Shuster J, Kirchner P, et al. Prognostic significance of cerebrospinal fluid (CSF) lymphoblasts (LB) at diagnosis (dx) in children with acute lymphoblastic leukemia (ALL). Proc Am Soc Clin Oncol 1994;13:317.Google Scholar
  14. 14.
    Gilchrist G, Tubergen D, Sather H, et al. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: A Children's Cancer Group Report. J Clin Oncol 1994; 12:2594–2600.PubMedGoogle Scholar
  15. 15.
    Heideman R, Packer R, Albright L, Freeman C, Rorke L. Tumors of the central nervous system. Philadelphia: Lippincott-Raven; 1997.Google Scholar
  16. 16.
    DeAngelis L. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998; 38:245–252.PubMedCrossRefGoogle Scholar
  17. 17.
    Gajjar A, Fouladi M, Walter AW, et al. Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors. J Clin Oncol 1999; 17:1825–1828.PubMedGoogle Scholar
  18. 18.
    Kallmes D, Gray L, Glass J. High-dose gadolinium-enhanced MRI for diagnosis of meningeal metastases. Neuroradiology 1998; 40:23–26.PubMedCrossRefGoogle Scholar
  19. 19.
    Chamberlain M. Radioisotope CSF flow studies in leptomeningeal metastases. J Neurooncol 1998; 38:135–140.PubMedCrossRefGoogle Scholar
  20. 20.
    Glantz M, Hall W, Cole B, et al. Diagnosis, management and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer 1995; 75:2919–2931.PubMedGoogle Scholar
  21. 21.
    Bleyer W, Coccia P, Sather H, Level C, Lukens J, Niebrye D, Siegel S. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal meth0trexate dosage regimen. JClin Oncol 1983; 1:317–325.Google Scholar
  22. 22.
    Ritchey A, Pollock B, Lauer S, et al. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia. J Clin Oncol 2000; 18:703.Google Scholar
  23. 23.
    Ritchey A, Pollock B, Lauer S, et al. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia. J Clin Oncol 1999; 17:3745–3752.PubMedGoogle Scholar
  24. 24.
    Moser A, Adamson PC, Gillespie A, Poplack D, Balis F. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer 1999; 85:511–516.PubMedCrossRefGoogle Scholar
  25. 25.
    Howell S, Gantz M, LaFollette S, Jaeckle K, Shapiro W. A controlled trial of Depocyt for the treatment of lymphomatous meningitis. In: Proc Am Soc Clin Oncol 1999:10a.Google Scholar
  26. 26.
    Kim S, Chatelut E, et al. Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol 1993; 11:2186–2193.PubMedGoogle Scholar
  27. 27.
    Blaney S, Poplack D. Neoplastic meningitis: diagnosis and treatment considerations. Medical Oncology 2000; 17:151–162.PubMedGoogle Scholar
  28. 28.
    van Besien K, Przepiorka D, Mehra R, et al. Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies. J Clin Oncol 1996 14:3036–3042.PubMedGoogle Scholar
  29. 29.
    Shad A, Magrath I. Malignant non-Hodgkin's lymphomas in children. In: Pizzo P, Poplack D, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott-raven; 1997.Google Scholar
  30. 30.
    Chamberlain M. A review of leptomeningeal metastases in pediatrics. J Child Neurol 1995; 10:191–199.PubMedGoogle Scholar
  31. 31.
    Grossman S, Moynihan T. Neurologic complications of systemic cancer; neoplastic meningitis. Neurol Clin 1991; 9:843–856.PubMedGoogle Scholar
  32. 32.
    Stanley P, Senac MJ, Segall H. Intraspinal seeding from intracranial tumors in children. Am J Neuroradiol 1984; 5:805–809.Google Scholar
  33. 33.
    Kandt R, Shinnar S, D'Souza B, et al. Cerebrospinal metastases in malignant childhood astrocytomas. J Neurooncol 1984; 2:123–128.PubMedCrossRefGoogle Scholar
  34. 34.
    Civitello L, Packer R, Rorke L. Leptomeningeal dissemination of low-grade gliomas in childhood. Neurology 1988; 38:562–566.PubMedGoogle Scholar
  35. 35.
    Grabb P, Albright A, Pang D. Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery. 1992; 30:64–71.PubMedGoogle Scholar
  36. 36.
    Wallner K, Wara W, Sheline G, Davis R. Intracranial ependymomas: Results of treatment with partial or whole brain irradiation without spinal irradiation. Int J Radiat Oncol Biol Phys 1983; 12:1937–1941.Google Scholar
  37. 37.
    Linstadt D, Wara W, Edwards M, Hudgins R, Sheline G. Radiotherapy of primary intracranial germinomas: The case against routine craniospinal irradiation. Int J Radiat Oncol Biol Phys 1988; 15:291–297.PubMedCrossRefGoogle Scholar
  38. 38.
    Packer R, Siegel K, Sutton L, et al. Leptomeningeal dissemination of primary central nervous system tumors of childhood. Ann Neurol 1985; 18:217–221.PubMedCrossRefGoogle Scholar
  39. 39.
    Allen J, Epstein F. Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS. The effect of patients' age and extent of disease on prognosis. J Neurosurg 1982; 57:446–451.PubMedGoogle Scholar
  40. 40.
    Deutsch M, Reigel D. The value of myelography in the management of childhood medulloblastoma. Cancer 1980; 45:2194–2197.PubMedGoogle Scholar
  41. 41.
    Grill J, Renaux VK, Bulteau C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 1999; 45:137–145.PubMedCrossRefGoogle Scholar
  42. 42.
    Gajjar A, Kuhl J, Epelman S, Bailey C, Allen J. Chemotherapy of medulloblastoma. Childs Nerv Syst 1999; 15:554–562.PubMedCrossRefGoogle Scholar
  43. 43.
    Packer RJ, Finlay JL. Chemotherapy for childhood medulloblastoma and primitive neuroectodermal tumors. Oncologist 1996; 1:381–393.PubMedGoogle Scholar
  44. 44.
    Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999; 17:832–845.PubMedGoogle Scholar
  45. 45.
    Chamberlain M, Kormanik P. Chronic oral VP-16 for recurrent medulloblastoma. Pediatr Neuro 1997; 17:230–234.CrossRefGoogle Scholar
  46. 46.
    Ashley D, Meier L, Kerby T, et al. Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol 1996; 14:1922–1927.PubMedGoogle Scholar
  47. 47.
    Heideman RL. Overview of the treatment of infant central nervous system tumors: medulloblastoma as a model. J Pediatr Hematol Oncol 2001; 23:268–271.PubMedCrossRefGoogle Scholar
  48. 48.
    Duffner P, Horowitz M, Krischer J. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. New Engl J Med 1993; 24:1725–1731.CrossRefGoogle Scholar
  49. 49.
    Geyer J, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Children's Cancer Group. J Clin Oncol 1994; 12:1607–1615.PubMedGoogle Scholar
  50. 50.
    Mason W, Grovas A, Halpern S. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 1998; 16:210–221.PubMedGoogle Scholar
  51. 51.
    Walter AW, Mulhern RK, Gajjar A. Survival and neurodevelopmental outcome of young children with medulloblastoma at St. Jude Children's Research Hospital. J Clin Oncol 1999;17:3720–3728.PubMedGoogle Scholar
  52. 52.
    Pollack I, Gerszten P, Martinez A, et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 1995;37: 655–667.PubMedGoogle Scholar
  53. 53.
    Packer R, Allen J, Nielsen S, Petito C, Deck M, Jereb B. Brainstem glioma: clinical manifestations of meningeal gliomatosis. Ann Neurol 1983;14:177–182.PubMedCrossRefGoogle Scholar
  54. 54.
    Pollack I, Hurtt M, Pang D, Albright A. Dissemination of low grade intracranial astrocytomas in children. Cancer 1994;73:2869–2878.PubMedGoogle Scholar
  55. 55.
    Dirks P, Jay V, Becker L, Drake J, Humphrey R, Hoffman H, Ruthka J. Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 1994;34:68–78.PubMedGoogle Scholar
  56. 56.
    Obana W, Cogen P, Davis R, Edwards M. Metastatic juvenile pilocytic astrocytoma. Case report. J Neurosurg 1991; 75:972–975.PubMedGoogle Scholar
  57. 57.
    Bruggers C, Friedman H, Phillips P, et al. Leptomeningeal dissemination of optic pathway gliomas in three children. Am J Ophthalmol 1991; 111:719–723.PubMedGoogle Scholar
  58. 58.
    Tamura M, Zama A, Kurihara H, et al. Management of recurrent pilocytic astrocytoma with leptomeningeal dissemination of childhood. Child's Nerv Syst 1998; 14:617–622.CrossRefGoogle Scholar
  59. 59.
    Shapiro K, Shulman K. Spinal cord seeding from cerebellar astrocytomas. Child's Brain 1976; 2:177–186.PubMedCrossRefGoogle Scholar
  60. 60.
    Kocks W, Kalff R, Reinhardt V, Grote W, Hilke J. Spinal metastasis of pilocytic astrocytoma of the chiasma opticum. Child's Nerv Syst 1989; 5:118–120.CrossRefGoogle Scholar
  61. 61.
    Paulino A, Thomas C, Slomiany D, Suarez C. Diffuse malignant leptomeningeal gliomatosis in a child: A case report and review of the literature. Am J Clin Oncol 1999; 22:243–246.PubMedCrossRefGoogle Scholar
  62. 62.
    Dietrich P-Y, Aapro M, Rieder A, Pizzolato G. Primary diffuse leptomeningeal gliomatosis (PDLG): a neoplastic cause of chronic meningitis. J Neurooncol 1993; 15:275–283.PubMedCrossRefGoogle Scholar
  63. 63.
    Ho K, Hoschner J, Wolfe D. Primary leptomeningeal gliomatosis. Symptoms suggestive of meningitis. Arch Neurol 1981; 38:662–666.PubMedGoogle Scholar
  64. 64.
    Ng H-K, Poon W-S. Diffuse leptomeningeal gliomatosis with oligodendroglioma. Pathology 1999; 31:59–63.PubMedCrossRefGoogle Scholar
  65. 65.
    Kitahara M, Katakura R, Wada T, Maniki T, Suzuki J. Diffuse form of primary leptomeningeal gliomatosis. J Neurosurg 1985; 63:283–287.PubMedGoogle Scholar
  66. 66.
    Jennings M, Gelman R, Hochberg F. Intracranial germ-cell tumors: Natural history and pathogenesis. J Neurosurg 1985; 63:155–167.PubMedGoogle Scholar
  67. 67.
    Buckner J, Peethambaram P, Smithson W, et al. Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors. J Clin Oncol 1999; 17:933–940.PubMedGoogle Scholar
  68. 68.
    Allen J, Kim J, Packer R. Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. J Neurosurg 1987; 67:65–70.PubMedCrossRefGoogle Scholar
  69. 69.
    Chow E, Reardon D, Shah A, et al T. Pediatric choroid plexus neoplasms. Int J Radiation Oncology Biol Phys 1999; 44:249–254.CrossRefGoogle Scholar
  70. 70.
    Allen J, Wisoff J, Helson L, Pearce J, Arenson E. Choroid plexus carcinoma— responses to chemotherapy alone in newly diagnosed young children. J Neurooncol 1992; 12:69–74.PubMedCrossRefGoogle Scholar
  71. 71.
    Boyd M, Steinbok P. Choroid plexus tumors: Problems in diagnosis and management. J Neurosurg 1987; 66:800–805.PubMedGoogle Scholar
  72. 72.
    Sheikh B, Siqueira E, Dayel F. Meningioma in children: A report of nine cases and review of the literature. Surg Neurol 1996; 45:328–335.PubMedCrossRefGoogle Scholar
  73. 73.
    Chan R, Thompson G. Intracranial meningiomas in childhood. Surg Neurol 1984; 21:319–322.PubMedCrossRefGoogle Scholar
  74. 74.
    Crouse S, Berg B. Intracranial meningiomas in childhood and adolescence. Neurology 1972; 22:135–141.PubMedGoogle Scholar
  75. 75.
    Diaz P, Maillo A, Morales F, Gomez-Moreta J, Hernandez J. Multiple meningiomas of the fourth ventricle in infancy: case report. Neurosurgery 1990;26: 1057–1060.PubMedGoogle Scholar
  76. 76.
    Donovan W, Govoni A. An 11 year-old boy with a history of AML and new onset headaches. Clinical Imaging 1992; 16:272–276.PubMedCrossRefGoogle Scholar
  77. 77.
    Hope J, Armstrong D, Babyn P, et al. Primary meningeal tumors in children: correlation of clinical and CT findings with histologic type and prognosis. Am J Neuroradiol 1992; 13:1353–1364.PubMedGoogle Scholar
  78. 78.
    Kamiya K, Inagawa T, Nagasako R. Malignant intraventricular meningioma with spinal metastasis through the cerebrospinal fluid. Surg Neurol 1989; 32:213–218.PubMedCrossRefGoogle Scholar
  79. 79.
    Miller A, Ramsden F. Malignant meningioma with extracranial metastases and seeding of the subarachnoid space and the ventricles. Pathol Eur 1972; 7:167–175.PubMedGoogle Scholar
  80. 80.
    Jallo G, Kothbauer K, Silvera V, Epstein F. Intraspinal clear cell meningioma: Diagnosis and management: Report of two cases. Neurosurgery 2001; 48:218–222.PubMedCrossRefGoogle Scholar
  81. 81.
    Lee W, Chang K-H, Cho G, et al. MR Imaging features of clear-cell meningioma with diffuse leptomeningeal seeding. Am J Neuroradiol 2000; 21:130–132.PubMedGoogle Scholar
  82. 82.
    Meli F, Boccaleri C, Manzitti J, Lylyk P. Meningeal dissemination of retinoblastoma: CT findings in eight patients. AJNR. 1990;11:983–986.PubMedGoogle Scholar
  83. 83.
    Blatt J, Fitz C, Mirro, Jr J. Recognition of central nervous system metastases in children with metastatic primary extracranial neuroblastoma. Pediatr Hematol Oncol 1997; 14:233–241.PubMedCrossRefGoogle Scholar
  84. 84.
    Kellie S, Hayes F, Bowman L, et al. Primary extracranial neuroblastoma with central nervous system metastases characterization by clinicopathologic findings and neuroimaging. Cancer 1991; 68:1999–2006.PubMedGoogle Scholar
  85. 85.
    Rohrlich P, Hartmann O, Couanet D, et al. Localizations neuro-meningees metastatiques secondaires dans les neuroblastomes de l'enfant. Arch Fr Pediatr 1989; 46:5–10.PubMedGoogle Scholar
  86. 86.
    Shaw P, Eden T. Neuroblastoma with intracranial involvement: an ENSG study. Med Pediatr Oncol 1992; 20:149–155.PubMedGoogle Scholar
  87. 87.
    Parasuraman S, Langston J, Rao B, et al. Brain metastases in pediatric Ewing's sarcoma and rhabdomyosarcoma: The St. Jude Children's Research Hospital experience. J Pediatr Hematol Oncol 1999; 21:370–377.PubMedCrossRefGoogle Scholar
  88. 88.
    Allcutt D, Michowicz M, Weitzman S, et al. Primary leptomeningeal melanoma: an unusually aggressive tumor in childhood. Neurosurg 1993; 32:721–729.Google Scholar
  89. 89.
    Rodriguez-Galindo C, Pappo A, Kaste S, et al. Brain metastases in children with melanoma. Cancer 1997; 79:2440–2445.PubMedCrossRefGoogle Scholar
  90. 90.
    Trigg M, Makuch R, Glaubiger D. Actuarial risk of isolated CNS involvement in Ewing's sarcoma following prophylactic cranial irradiation and intrathecal methotrexate. Int J Radiation Oncology Biol Phys 1985; 11:699–702.Google Scholar
  91. 91.
    Yu L, Craver R, Baliga M, et al. Isolated CNS involvement in Ewing's sarcoma. Med Pediatr Oncol 1990; 18:354–358.PubMedGoogle Scholar
  92. 92.
    Wharam MJ. Rhabdomyosarcoma of parameningeal sites. Semin Radiat Oncol 1997; 7:212–216.PubMedCrossRefGoogle Scholar
  93. 93.
    Russell D, Rubinstein L. Pathology of Tumours of the Nervous System. 3d ed. Baltimore: Williams & Wilkins; 1971.Google Scholar
  94. 94.
    Krill A. Krill's Hereditary Retinal and Choroidal Diseases. New York: Harper & Row; 1977.Google Scholar
  95. 95.
    Davis P, Friedman N, Fry S, Malko J, Hoffman JJ, Braun I. Leptomeningeal metastasis: MR imaging. Radiology 1987; 163:449–454.PubMedGoogle Scholar
  96. 96.
    Donaldson S, Egbert E, Lee W-H. Retinoblastoma. In: Pizzo P, Poplack P, eds. Principles and Practice of Pediatric Oncology. Philadelphia: J.B. Lippincott Co; 1989:683–696.Google Scholar
  97. 97.
    Kramer K, Kushner B, Heller G, Cheung N-K. Neuroblastoma metastatic to the central nervous system. Cancer 2001; 91:1510–1519.PubMedCrossRefGoogle Scholar
  98. 98.
    Trigg M, Glaubiger D, Nesbit M. The frequency of isolated CNS involvement in Ewing's sarcoma. Cancer 1982; 49:2404–2409.PubMedGoogle Scholar
  99. 99.
    Makin G, Eden O, Lashford L, et al. Leptomeningeal melanoma in childhood. Cancer 1999; 86:878–886.PubMedCrossRefGoogle Scholar
  100. 100.
    Poe L, Roitberg D, Galyon D. Neurocutaneous melanosis presenting as an intradural mass of the cervical canal: magnetic resonance features and the presence of melanin as a clue to diagnosis: case report. Neurosurgery 1994; 35:741–743.PubMedGoogle Scholar
  101. 101.
    Eaves F, Burstein F, Hudgins R, Cohen S, Papciack M. Primary temporal melanoma without diffuse leptomeningeal involvement: variant of neurocutaneous melanosis. Plastic Reconstr Surg. 1995;95:133–136.CrossRefGoogle Scholar
  102. 102.
    Frieden I, Williams M, Barkovich A. Giant congenital melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children. J Am Acad Dermatol 1994; 31:423–429.PubMedCrossRefGoogle Scholar
  103. 103.
    Blasberg R, Patlak C, Fenstermacher J. Intrathecal chemotherapy brain tissue profiles after ventriculo-cisternal perfusion. Pharm Exp Ther 1975; 195:73–83.Google Scholar
  104. 104.
    Poplack D, Bleyer W, Horowitz M. Pharmacology of antineoplastic agents in cerebrospinalfluid. New York: Plenum Press; 1980.Google Scholar
  105. 105.
    Kaplan R, Wiernik P. Neurotoxicity of antineoplastic drugs. Semin Oncol 1982; 9:103–130.PubMedGoogle Scholar
  106. 106.
    Blaney S, Poplack D. Pharmacologic strategies for the treatment of meningeal malignancy. Investigational New Drugs 1996; 14:69–85.PubMedCrossRefGoogle Scholar
  107. 107.
    Voorhess M, Brecker M, Glickman A, et al. Hypothalamic-pituitary function of children with acute lymphocytic leukemia after three forms of central nervous system prophylaxis. A retrospective study. Cancer 1986; 57:1287–1291.PubMedGoogle Scholar
  108. 108.
    Pasqualini T, McCalla J, Berg S, et al. Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemia. Acta Endocrinol (Copenh) 1991; 124:375–380.PubMedGoogle Scholar
  109. 109.
    Blatt J, Bercu B, Gillin J, Mendelson W, Poplack D. Reduced pulsatile growth hormone secretion in children after therapy for acute lympoblastic leukemia. J Pediatr 1984; 104:182–186.PubMedGoogle Scholar
  110. 110.
    Moss H, Nannis E, Poplack D. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med 1981; 71:47–52.PubMedCrossRefGoogle Scholar
  111. 111.
    Paolucci G, Rosito P. Adverse sequelae of central nervous system prophylaxis in acute lymphoblastic leukemia. Boston: Martinus Nijhoff; 1983.Google Scholar
  112. 112.
    Poplack D. Evaluation of adverse sequelae of central nervous sustem prophylaxis in acute lymphoblstic leukemia. Boston: Martinus Nijhoff; 1983.Google Scholar
  113. 113.
    Radcliff J, Packer R, Atkins T, et al. Prospective study of cognitive function in children with medulloblastoma receiving whole brain radiotherapy and chemotherapy. Ann Neurol 1992; 32:551–555.CrossRefGoogle Scholar
  114. 114.
    Johnson D, McGabe M, Nicholson H, et al. Quality of long-term survival in young children with medulloblastoma. J Neurosurg 1994; 80:1004–1010.PubMedCrossRefGoogle Scholar
  115. 115.
    MacLean W, Noll R, Stehbens J, et al. Neuropsychological effects of cranial irradiation in young children with acute lymphoblastic leukemia 9 months after diagnosis. Arch Neurol 1995; 52:156–160.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Kathleen A. Neville
    • 1
  • Susan M. Blaney
    • 1
  1. 1.Texas Children's Cancer CenterBaylor College of MedicineHouston

Personalised recommendations